Document is current

Article History

Received: 14 August 2024

Accepted: 26 September 2024

First Online: 29 October 2024

Declarations

:

: Gordon Smith received consulting fees from Abalone, Alexion, Argenx, Disarm Therapeutics, Eidos, Lexicon, and Sangamo. Gil Wolfe received consulting fee from Grifols, Alexion, Argenx, Takeda, BPL, UCB, Cartesian, and Janssen, research support from ArgenX, Ra/UCB, Immunovant, Roche, Alexion, Sanofi, NINDS/NIH, MGFA, and public speaking honoraria from Grifols, Alexion, UCB. Ali A. Habib received research support from Alexion/Astra Zeneca, Argenx, UCB, Immunovant, Regeneron, CabalettaBio, VielaBio, Pfizer, and Genentech, as well as honoraria from UCB, Argenx, Alexion, Immunovant, and Regeneron. Cynthia Qi, Deborah Gelinas, Edward Brauer, and Glenn Phillips are employees of Argenx. Hongbo Yang, Mandy Du, and Xin Chen are employees of Analysis Group Inc., which received consulting fees from Argenx to conduct this study. Francesco Saccà received public speaking honoraria from Alexion, argenx, Biogen, Genpharm, Medpharma Madison Pharma, Zai Lab; he also received compensation for Advisory boards or consultation fees from Alexion, argenx, Biogen, Dianthus, Lexeo Therapeutics, Novartis, Reata, Sandoz; he is PI in clinical trials for Alexion, argenx, Immunovant, Lediant, Novartis, Prilenia, Remgen, Sanofi.

: This study used anonymized, previously collected, or publicly published data; thus, no ethical review was required. All the original trials included in this study received institutional review board approval and patient consent. This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments.